![Daniel S. Grau](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Daniel S. Grau
Chief Executive Officer at
Theriana Pharmaceuticals, Inc.
Profile
Daniel S.
Grau was the founder of Sojournix, Inc. (founded in 2016) where he held the title of President, Chief Executive Officer & Director.
He is currently the President, CEO, Secretary, Treasurer & Director at Theriana Pharmaceuticals, Inc., Chairman at Lusaris Therapeutics, Inc., and Director at AbCellera Boston, Inc. (since 2019).
In his former positions, he served as Vice Chairman & Chief Executive Officer at Cortria Corp., President & Chief Executive Officer at Avilar Therapeutics, Inc., and Director at Concert Pharmaceuticals, Inc. He was also a Director at Therapeutics Acquisition Corp.
and President at Nxera Pharma UK Ltd. Additionally, he worked as the Chief Operating Officer at CombinatoRx, Inc. from 2001 to 2008 and as a Management Consultant at Pharmacia Corp.
Mr. Grau completed his undergraduate degree at Davidson College and his graduate degree at Yale University.
Daniel S. Grau active positions
| Companies | Position | Start |
|---|---|---|
Theriana Pharmaceuticals, Inc.
 Theriana Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Operates pharmaceutical stores | Chief Executive Officer | - |
AbCellera Boston, Inc.
 AbCellera Boston, Inc. BiotechnologyHealth Technology Produces vaccines for plant, animal and human diseases | Director/Board Member | 2019-05-01 |
Lusaris Therapeutics, Inc.
 Lusaris Therapeutics, Inc. BiotechnologyHealth Technology Develops small-molecule neuroplastogen therapeutics for neuropsychiatric and neurological disorders | Chairman | - |
Former positions of Daniel S. Grau
| Companies | Position | End |
|---|---|---|
CombinatoRx, Inc.
 CombinatoRx, Inc. Pharmaceuticals: OtherHealth Technology Develops new medicines built from synergistic combinations of approved drugs | Chief Operating Officer | 2008-05-05 |
Avilar Therapeutics, Inc.
 Avilar Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which develops covalent drugs to treat cancer and other autoimmune diseases | Chief Executive Officer | - |
| THES ACQU | Director/Board Member | - |
Sojournix, Inc.
 Sojournix, Inc. BiotechnologyHealth Technology Operates in the healthcare industry focusing on biotechnology business | Founder | - |
Nxera Pharma UK Ltd.
 Nxera Pharma UK Ltd. Pharmaceuticals: MajorHealth Technology Designs and develops new medicines targeting G protein-coupled receptors | President | - |
Training of Daniel S. Grau
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
45
1st degree connections
13
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 13 |
|---|---|
CombinatoRx, Inc.
CombinatoRx, Inc. Pharmaceuticals: OtherHealth Technology Develops new medicines built from synergistic combinations of approved drugs | Health Technology |
Concert Pharmaceuticals, Inc.
 Concert Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel medicines | Health Technology |
Cortria Corp.
 Cortria Corp. Pharmaceuticals: MajorHealth Technology Develops drugs for cardiovascular disease | Health Technology |
AbCellera Boston, Inc.
AbCellera Boston, Inc. BiotechnologyHealth Technology Produces vaccines for plant, animal and human diseases | Health Technology |
Pharmacia Corp.
 Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Researches, manufactures and sells pharmaceuticals | Health Technology |
Davidson College
 Davidson College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nxera Pharma UK Ltd.
Nxera Pharma UK Ltd. Pharmaceuticals: MajorHealth Technology Designs and develops new medicines targeting G protein-coupled receptors | Health Technology |
Sojournix, Inc.
Sojournix, Inc. BiotechnologyHealth Technology Operates in the healthcare industry focusing on biotechnology business | Health Technology |
Theriana Pharmaceuticals, Inc.
Theriana Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Operates pharmaceutical stores | Retail Trade |
Therapeutics Acquisition Corp.
 Therapeutics Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Avilar Therapeutics, Inc.
Avilar Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which develops covalent drugs to treat cancer and other autoimmune diseases | Commercial Services |
Lusaris Therapeutics, Inc.
Lusaris Therapeutics, Inc. BiotechnologyHealth Technology Develops small-molecule neuroplastogen therapeutics for neuropsychiatric and neurological disorders | Health Technology |
- Stock Market
- Insiders
- Daniel S. Grau
